# Towards Faithful and Controllable Personalization via Critique-Post-Edit Reinforcement Learning

Preprint · Chenghao Zhu, Meiling Tao, Tiannan Wang, Dongyi Ding, Yuchen Eleanor Jiang, Wangchunshu Zhou

- Archive id: arxiv:2510.18849
- Published: 2025-10-21
- arXiv: https://arxiv.org/abs/2510.18849
- Source URL: https://arxiv.org/abs/2510.18849
- PDF: https://arxiv.org/pdf/2510.18849
- Provenance: arxiv

## Abstract

Faithfully personalizing large language models (LLMs) to align with individual user preferences is a critical but challenging task. While supervised fine-tuning (SFT) quickly reaches a performance plateau, standard reinforcement learning from human feedback (RLHF) also struggles with the nuances of personalization. Scalar-based reward models are prone to reward hacking which leads to verbose and superficially personalized responses. To address these limitations, we propose Critique-Post-Edit, a robust reinforcement learning framework that enables more faithful and controllable personalization. Our framework integrates two key components: (1) a Personalized Generative Reward Model (GRM) that provides multi-dimensional scores and textual critiques to resist reward hacking, and (2) a Critique-Post-Edit mechanism where the policy model revises its own outputs based on these critiques for more targeted and efficient learning. Under a rigorous length-controlled evaluation, our method substantially outperforms standard PPO on personalization benchmarks. Personalized Qwen2.5-7B achieves an average 11\\% win-rate improvement, and personalized Qwen2.5-14B model surpasses the performance of GPT-4.1. These results demonstrate a practical path to faithful, efficient, and controllable personalization.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.